IPCS (1978). Principles and Methods for Evaluating the Toxicity of Chemicals. Part I. International Programme on Chemical Safety. Environmental Health Criteria 6. (Accessed 13.6.02) pp. Geneva, Switzerland: WHO. Web site: http//www.who.int/pcs/pubs/pub_meth.htm.
2.
BUAV (2001). Action to End Animal Testing. The Way Forward, 19 pp. London, UK: British Union for the Abolition of Vivisection.
3.
KroesR., & FeronV.J. (1990). Toxicity testing: strategies and conduct. In Progress in Predictive Toxicology (ed. ClaysonD.B., MunroI.C., ShubikP., & SwenbergJ.A.), pp 15–39. New York, NY, USA: Elsevier Science.
FrazierJ.M. (1994). The role of mechanistic toxicology in test method validation. Toxicology in Vitro8, 787–791.
6.
StingeleS., CoeckeS., NicoteraP., & BallsM. (1999). EC Patent filed 27th August 1999 on Genetically Engineered Cell Lines, and Their Uses, in Particular for Neurotoxicity Testing. Patent No. 99402139.2–2106/International No. PCT/EP00/08223. Rijswijk, The Netherlands: European Patent Office.
7.
BremerS., WorthA.P., PaparellaM., BigotK., KolossovE., FleischmannB.K., HeschelerJ., & BallsM. (2001). Establishment of an in vitro reporter gene assay for developmental cardiac toxicity. Toxicology in Vitro15, 215–223.
DeJonghJ., VerhaarH.J., & HermensJ.L. (1997). A quantitative property–property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans. Archives of Toxicology72, 17–25.
10.
DeJonghJ., VerhaarH.J.M., & HermensJ.L.M. (1998). Role of kinetics in acute lethality of nonreactive volatile organic compounds (VOCs). Toxicological Science45, 26–32.
11.
SoffersA.E.M.F., BoersmaM.G., VaesW.H.J., VervoortJ., TyrakowskaB., HermensJ.L.M., & RietjensI.M.C.M. (2001). Computer-modeling-based QSARs for analyzing experimental data on biotransformation and toxicity. Toxicology in Vitro15, 539–551.
12.
BlaauboerB.J., BarrattM.D., & HoustonJ.B. (1999). The integrated use of alternative methods in toxicological risk evaluation. ECVAM integrated testing strategies task force report 1. ATLA27, 229–237.
13.
HanwayR.H., & EvansP.F. (2000). Read-across of toxicological data in the notification of new chemicals. Toxicology Letters116, Suppl. 1, 61.
14.
BarrattM.D. (2000). Principles of toxicity prediction from chemical structure. In Progress in Reduction, Refinement and Replacement in Animal Experimentation (ed. BallsM., van ZellerA-M., & HalderM.E.), pp. 449–456. Amsterdam, The Netherlands: Elsevier.
15.
BallsM., & FentemJ.H. (1992). The use of basal cytotoxicity and target organ toxicity tests in hazard identification and risk assessment. ATLA20, 368–388.
16.
FentemJ.H., ArcherG.E.B., BallsM., BothamP.A., CurrenR.D., EarlL.K., EsdaileD.J., HolzhütterH.G., & LiebschM. (1998). The ECVAM international validation study on in vitro tests for skin corrosivity. 2. Results and evaluation by the Management Team. Toxicology in Vitro12, 483–524.
17.
OECD (1998). Harmonized Integrated Hazard Classification System for Human Health and Environmental Effects of Chemical Substances, 65 pp. Paris, France: Organisation for Economic Cooperation and Development.
18.
SpielmannH., GenschowE., LiebschM., & HalleW. (1999). Determination of the starting dose for acute oral toxicity (LD50) testing in the Up-and-Down Procedure (UDP) from cytotoxicity data. ATLA27, 957–966.